Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
They are taking salaries just reduced them to try hold back the raise till this new tax year when AGM takes place.
It just defers payment and they will probably make it up by giving themselves loads of options to help reduce the damage of dilution.
The problem is selling isn’t it as now you get locked for dilution and it will be significantly higher than before.
At 0.18p. Thats 277 million shares to raise £500,000 take of costs of placing etc.
Problem is now it will probably have to incur part loan notes part raise part warrants to existing shareholders etc
A messy affair.
But needs must.
So as mentioned they had less money than most suspected on last accounts as I did.
They got pennies from NXP001 as I suspected.
NXP004 again not worth much but makes people think it’s not a one trick pony to feed the market with bluff!!!
AstraZeneca as mentioned by someone last night is no stranger to NFX and they haven’t paid millions to get the product that essentially makes their own powder slightly less needed. Thats what NXP004 managed lol
NXP002 to be of interest to market needs Orphan status or the hard sell gets even harder. Takes 3 months and no guarantee for EU granting for that topographical area. I’d expect even more work for US Asia etc!! So loads of work and time costs money. Legals cost money. Salaries travel cost money. Listing costs money. Few patents securities expected also soon but these cost money.
So expect the bowl to be presented as advised last year but they managed a few K for NXP001 and research back pay has let them push it further but that’s risky gamble letting the coffers empty. Nothing new here it’s been running like that since the start.
Ultimately though now it’s a one chance to try get this higher up the food chain or it’s bargain basement for BP’s to pick up if they cannot manage it themselves.
Nobody in a rush obviously to come grab NXP002 even at this pitiful price.
If it was so good and majors such as AZ see that then simply why haven’t they said hey we see you struggling and massively cheap for an IPF combined therapy drug here is 10mil and we will get this going????
Why?
It’s been available now for years and they know exactly what they are looking at!
What is it they cannot see that NFX has known for the last 6 years?? And telling them??
All I read from that chat is money will be needed. Orphan status will take months and then months more to even get a negotiated deal etc. minimum a year before we see any potential deal and that’s only if they get orphan status otherwise it’s going to be even harder.
Big risks and little wonga. Better vote for that raise imo !!!!
Avacta as we know genuinely would like to list in the US.
I think the AIM knows this fact and doesn’t want Avcta to succeed due to it voicing it’s opinion about how the UK market is just not a place to build sustainable growth companies that go to become unicorns.
AVACTA is being punished in anyway possible by the market and it’s definitely time Alastair and his BOD stand up and pull the plug on the AIM or dual list over in the states driving the price this side.
It would be if a) He was CEO but he isn’t?
b) If they were close to signing anything tangible, but they are no way close to that.
C) Probably ok to holiday as this is only a virtual business and finance for the raise is probably ready subject to VWAP upon AGM period!
Don’t tell anyone but Stephen Hawking is making a grand return tonight from his resting place to chat to any of the believers who want to pray 🙏 for him to find the elusive NXP002 formula. But it won’t help vertebra that’s been squashed falling down snow slopes.
Not a chance!!!
This company will not make enough to create enough cash to continue growth.
The figures are dropping when they were meant to be doubling year on year.
The model has had a decade to prove itself and it fails.
This will fail and any significant investor will ask the difficult questions from what’s evident here and either screw them down tight to take huge chunk of this company or walk away. So which will it be?
I’d definitely not be holding as I said the other day at 1.1p sell and wait till they complete funding as you will be able to buy much cheaper. Already saved you 50% or doubled your holding if daft enough to buy.
So here we have couple of posts from usual spamming clueless LSE posters who think by saying something enough then it becomes significant.
If you understand AVACTA and the shear amount of significant life changing data it is now shown and proven Precision works. AVA6k is working beyond belief and will become the go to for Chemo market within next year or two.
Then if they understood this they would realise that even if AVACTA have arranged funds from a strategic investor it makes the company significantly more valuable.
Therefore the close out is going to be a huge strong rebound in SP.
Only fools would be now betting against AVACTA and they deserve to lose money especially for what this company is achieving for humanity around the world!!
Problem with short sellers is they try interpret TA and that’s not 100% in any format and news changes the TA in ways they cannot predict reliably as it moves the value of the company up if good news data develops.
With a platform proven!! Previous lows have zero relevance now due to the value of the platform. Any route that cements that development further underlines this multi billion £ platform.
It’s not if BP buys AVACTA it’s just when and imo that’s already been scheduled as we speak subject to counter offers coming in upon announcements.
Well that is embarrassing that they feel the need to RNS a paid for media interview to try push SP up before raise!!!
I’d say nobody would invest cash here unless minimum 50% discounted and will want loan notes to convert to cover the risk.
IMO this will not dig its way out with the expensive limited reach it so happily try’s to push. That’s the problem!!!!!!
With all this current stupidity of short selling traders trying to shake the tree against this hugely growing redwood it’s laughable.
Get solid investment cash in and watch this rocket with the news stream ahead.
All the traders are doing is trying to get in cheaper. They missed it the other day. So those with shorts need to watch out as they are going to get burned shortly Big Time ;)!🕰️
The reason would be nothing to do with any pressing need for cash but the issue of looking vulnerable for takeovers.
They have huge interest from big pharmaceutical companies and to keep these away whilst they continue to build the picture for buoyant they need to show support. One way would be to use an interested party to put money in to take a slice of shares.
So an II like Goldman Sachs or equivalent placing significant cash in to show support is not only a massive showing of faith it also gives them working capital to see them through to negotiations for potential Buyout/ licensing deals etc. Along with the potential of DX sale and licensing of other indications and milestones from current partnerships, Avacta will be sitting in a super strong position.
This will silence a lot of ignorant people and enable them to release the groundbreaking data in the next period.
Huge times ahead. I doubt now you will be able to pick stock up at these levels for very much longer and the value increases will come at a much more rapid rate. This will be multiples within coming months.
Here they are trying to pump it before placing.
Fluff talk but the numbers don’t lie.
TB has had years talking and simply the model format does not work. A small amount raised will not see this company through as it needs to continue investment to grow.
Therefore it needs a big lump!!
This is where TB uses the UK market to raise funds and they are good at manipulating the SP before raising cash. You see it time and time again.
1mil at 0.3p is 333,333,333 million shares!!!
That’s what will happen here. Buying now is either manipulation or a little naive imo!
It’s a poor read fully of wants and hopes but the grim reality is they won’t become cash positive as to get anywhere to keep the wheel moving for growth you need to keep throwing more and more cash in or it stagnates and stops moving.
I feel it’s stuck and the problem is the exclusivity and limited reach of large turnover.
Stay clear imo.